Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Racheli Gueta

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|September 19, 2021
Mode of Action of RZL-012, a New Fat-Reducing MoleculeEran Blaugrund, Racheli Gueta, Anton Zernov, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|April 19, 2021
RZL-012, a New Fat Dissolving Molecule, Tested in Dercum's Disease PatientsRacheli Gueta, Eran Blaugrund, Alon Bloomenfeld, et al.
Aesthetic Surgery Journal. Open Forum|November 10, 2023
Tapencarium (RZL-012) for Flank Fat Reduction: A Proof-of-Concept StudySachin M Shridharani, MacKenzie L Kennedy, Racheli Gueta, et al.
Plastic and Reconstructive Surgery. Global Open|April 29, 2026
Pilot Study: Repeated Utenpanium (RZL-012) Treatment for Submental Fat ReductionSachin M Shridharani, Brian S Biesman, Racheli Gueta, et al.
Aesthetic Surgery Journal|June 22, 2023
Efficacy and Safety of Tapencarium (RZL-012) in Submental Fat ReductionSachin M Shridharani, Steven Dayan, Brian Biesman, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|September 19, 2021
Mode of Action of RZL-012, a New Fat-Reducing MoleculeEran Blaugrund, Racheli Gueta, Anton Zernov, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|April 19, 2021
RZL-012, a New Fat Dissolving Molecule, Tested in Dercum's Disease PatientsRacheli Gueta, Eran Blaugrund, Alon Bloomenfeld, et al.
Aesthetic Surgery Journal. Open Forum|November 10, 2023
Tapencarium (RZL-012) for Flank Fat Reduction: A Proof-of-Concept StudySachin M Shridharani, MacKenzie L Kennedy, Racheli Gueta, et al.
Plastic and Reconstructive Surgery. Global Open|April 29, 2026
Pilot Study: Repeated Utenpanium (RZL-012) Treatment for Submental Fat ReductionSachin M Shridharani, Brian S Biesman, Racheli Gueta, et al.
Aesthetic Surgery Journal|June 22, 2023
Efficacy and Safety of Tapencarium (RZL-012) in Submental Fat ReductionSachin M Shridharani, Steven Dayan, Brian Biesman, et al.
Pageof 1